A retrospective, single centre study analysing angiogenesis-related factors associated with nivolumab efficacy in patients with advanced refractory gastric cancer
Latest Information Update: 01 Mar 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Gastric cancer
- Focus Pharmacodynamics; Therapeutic Use
- 01 Mar 2021 New trial record
- 17 Jan 2021 Results presented at the 2021 Gastrointestinal Cancers Symposium